RAC

0.97%

$1.54 race oncology ltd

Thanks for your quick response, as always your input is greatly...

First 11094 Last

Share
Profile

Follow
bc17

20 Posts.

2

10/07/24

07:58

Post #: 74682198
Share

Originally posted by Mason14: ↑

Tumor response through a biological marker, efficacy, and then PFS in that order. M6A level change and how it correlates with responses. Biological marker is taken instantly, efficacy established after the first few courses of treatment, and PFS a more long-term marker.

Cardioprotection through typical measures as well as VO2PEAK most importantly. The obvious comparisons to make are cohorts receiving dexrazoxane as well as VO2PEAK cohorts receiving cardiotoxic regimens. Because VO2PEAK is very sensitive, it can measure cardiac damage within 6 months of dosing and give meaningful, comparable data.

The following criteria is required for excellent CPACS.

From what I can tell, RAC are gunning for a geographical licensing agreement for China, Japan, and South Korea where anthracycline dosing ranges from 12-14 million each year. Doxorubicin ranks number 1 as the most essential drug globally by almost 950 oncologists in 82 countries. The other anthracyclines to make the list of 100 compounds are Epirubicin (30), Danorubicin (64), Pegylated liposomal Doxorubicin (78), and Idarubicin (88). It's quite hard to find reliable information on frequency of dosing for Dox relate to its peers, but if oncologists see it as the most essential anti-cancer agent on the planet, then we can assume it's used frequently.

I suspect that this is it, big man. No more hiding. Information will be rapidly shared down the line to strike a geographical licensing agreement for the use of Bisantrene in these countries off-label. JDP and I speak quite regularly, and he certainly knows a lot more than I do regarding these deals, so I would pay attention to him.

Expand

Thanks for your quick response, as always your input is greatly appreciated.

RAC Price at posting: $1.75 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

MGU

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Is oil undervalued?

DVP

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

VMT

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

VMS

Venture to sniff out high-grade REE targets at Jupiter project, WA

BOE

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

NXG

Cost blow-out for Rook I uranium project sees share plummet for NexGen

WGX

Westgold sets its sights on top five producer status through merger with Karora

GRX

GreenX picks up prospective copper project in Germany

There are more pages in this discussion • 137 more messages in this thread...

First 11094 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.54		Change -0.015(0.97%)		Mkt cap ! $261.5M

Open	High	Low	Value	Volume
$1.55	$1.55	$1.50	$111.4K	73.35K

Buyers (Bids)

No.	Vol.	Price($)
1	500	$1.53

Sellers (Offers)

Price($)	Vol.	No.
$1.56	1400	1

View Market Depth

No.	Vol.	Price($)
1	500	1.525
1	828	1.505
2	4000	1.490
1	38500	1.480
3	22244	1.450

Price($)	Vol.	No.
1.555	1400	1
1.640	1000	1
1.650	14314	2
1.690	585	1
1.745	12000	1

Last trade - 16.10pm 02/08/2024 (20 minute delay)

RAC (ASX) Chart

Thanks for your quick response, as always your input is greatly...

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Is oil undervalued?

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Venture to sniff out high-grade REE targets at Jupiter project, WA

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Westgold sets its sights on top five producer status through merger with Karora

GreenX picks up prospective copper project in Germany

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks for your quick response, as always your input is greatly...

Top Stories

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Is oil undervalued?

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Venture to sniff out high-grade REE targets at Jupiter project, WA

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Westgold sets its sights on top five producer status through merger with Karora

GreenX picks up prospective copper project in Germany

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News